Sosei

International Biopharma specializing in GPCR structure-based drug design, peptide and nanotechnology

placeChiyoda City, Tokyo, Japan calendar_todayFounded 1990 groups211 employees language sosei.com

Innovation

6 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 52 times.

YearFilings
20161

Investor mix

12 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital650%
Private equity18%
Bank & private debt18%
Other / undisclosed433%
Coming soon